DOXYCYCLINE HYCLATE | A062269 | EPIC PHARMA LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lachman Consultant Services, Inc. FDA-2021-P-0852 · 2 docket documents Lachman Consultant Services, Inc. filed this citizen petition on behalf of a client requesting that the FDA determine Doxycycline Hyclate Tablets USP at a strength of 62.5 mg equivalent base per tablet is suitable for submission in an ANDA, citing that this intermediate strength would provide improv | Other | 2021-08-03 | Open | Lachman Consultant Services, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.1176
per ea
Lowest NADAC/Unit
$0.1176
per ea
Brand NDCs
0
Generic NDCs
11
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 24658031001DOXYCYCLINE HYCLATE 100 MG TAB | $0.1176 | EA | Generic | — | 2026-06-17 |
| 24658031005DOXYCYCLINE HYCLATE 100 MG TAB | $0.1176 | EA | Generic | — | 2026-06-17 |
| 24658031007DOXYCYCLINE HYCLATE 100 MG TAB | $0.1176 | EA | Generic | — | 2026-06-17 |
| 24658031008DOXYCYCLINE HYCLATE 100 MG TAB | $0.1176 | EA | Generic | — | 2026-06-17 |
| 24658031010DOXYCYCLINE HYCLATE 100 MG TAB | $0.1176 | EA | Generic | — | 2026-06-17 |
| 24658031020DOXYCYCLINE HYCLATE 100 MG TAB | $0.1176 | EA | Generic | — | 2026-06-17 |
Showing 6 of 11 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.